Skip to main content

Month: August 2020

Rovio Entertainment Oyj: Omien osakkeiden hankinta 14.08.2020

Lisätietoja:Rene Lindell, talousjohtaja+358 207 888 300 (vaihde)RovioIR@rovio.comJakelu:Nasdaq Helsinki OyjKeskeiset tiedotusvälineethttps://investors.rovio.com/fiRovio lyhyesti:Rovio Entertainment Oyj on maailmanlaajuinen, peleihin keskittyvä viihdeyhtiö, joka luo, kehittää ja julkaisee mobiilipelejä, joita on jo tähän mennessä ladattu 4,5 miljardia kertaa. Rovio tunnetaan parhaiten Angry Birds -brändistään, joka sai alkunsa mobiilipelistä vuonna 2009 ja on sittemmin lisensointinsa kautta laajentunut peleistä erilaisiin viihde- ja kuluttajatuotekategorioihin. Tänään Rovio tarjoaa useita mobiilipelejä, animaatioita ja on tuottanut Angry Birds -elokuvan, joka oli ensi-iltaviikonloppunaan lipputulojen kärjessä 50 maassa, ja jonka jatko-osan, Angry Birds -elokuva 2 julkaistiin elokuussa 2019. Rovion pääkonttori on Espoossa ja yhtiö on listattu...

Continue reading

Ress Life Investments A/S:

                                                                                                             Ress Life Investments                                                                                                             Holbergsgade 14, 2 tv                                                                                                             DK-1057 Copenhagen K                                                                                                             Denmark                                                                                                             CVR nr. 33593163                                                                                                             www.resslifeinvestments.comTo: Nasdaq CopenhagenDate: 14 August 2020Corporate Announcement 29/2020Ress Life...

Continue reading

SAGE and LifeCents Partner on Financial Wellness Program for LGBT Elders

New York, Aug. 14, 2020 (GLOBE NEWSWIRE) — SAGE, the world’s largest and oldest organization dedicated to improving the lives of LGBT elders, partnered with LifeCents to develop and launch SAGECents, a unique version of the app built specifically for LGBT elders. This program was created to ensure LGBT elders have access to resources that will support their financial literacy and stability. The digital wellness platform, created with support from the Wells Fargo Foundation, will help SAGE constituents navigate the unprecedented economic environment resulting from the COVID-19 pandemic.SAGECents aims to combat the difficulty of navigating economic uncertainty, especially at a time when access to a number of services and opportunities for LGBT elders is limited. With LGBT elders at the epicenter of the pandemic – due to their age,...

Continue reading

Tauriga Sciences, Inc. Now a Certified Supplier for the Following Major Supermarket Chains: Food Lion, Stop & Shop, Giant, Hannaford, Martin’s and Peapod

NEW YORK, NY, Aug. 14, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of functional “supplement” chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as two ongoing Biotechnology initiatives, today announced that the Company has become a certified Supplier at the following major supermarket chains:  Food Lion, Stop & Shop, Giant, Hannaford, Martin’s and Peapod.  The Company is operating through the SupplierOne Platform (“SupplierOne”), which is used by more than 1,200 Buyers and 330 Buying Companies.       The Company’s entire Tauri-Gum™ product line, inclusive of the requisite documentation (supplemental information), is now...

Continue reading

Ureteroscope Market to Touch $1,498.1 Million by 2027; Increasing Demand for Efficient Kidney Stone Removal Devices Worldwide to Aid Market Growth: Fortune Business Insights™

Pune, Aug. 14, 2020 (GLOBE NEWSWIRE) — The global ureteroscope market size is projected to reach USD 1,498.1 million by 2027, exhibiting a CAGR of 5.5% during the forecast period. Increasing incidence of kidney stones is expected to stoke adoption of these devices, states Fortune Business Insights™ in its report, titled “Ureteroscope Market Size, Share & COVID-19 Impact Analysis, By Product (Flexible, Semi-flexible, and Rigid), By Application (Urolithiasis, Urolithial Carcinoma, and Others), End User (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2020-2027”.A study published by the US National Institutes of Health (NIH) in 2018 revealed that kidney stone disease prevalence and its recurrence is rising. According to the study, 12% of the global population suffers from urolithiasis, which is the process of...

Continue reading

Biostimulants Market Size Worth USD 5.35 Billion at 10.65% CAGR by 2027; Increasing Incidence of Abiotic Land Stress Worldwide to Propel Demand, Says Fortune Business Insights™

Pune, Aug. 14, 2020 (GLOBE NEWSWIRE) — The global biostimulants market size is expected to showcase an exponential growth by reaching USD 5.35 billion by 2027 while exhibiting a CAGR of 10.65% between 2020 and 2027. This is attributable to the increasing incidence of abiotic stress inland and the growing demand for organic food products across the globe. This information is published by Fortune Business Insights, in its latest report, titled, “Biostimulants Market Size, Share & COVID-19 Impact Analysis, By Source (Microbial, Non-Microbial), Active Ingredients (Seaweed Extracts, Humic Substances, Vitamins & Amino Acids, Microbial Amendments, Others), Application (Foliar Application, Soil Treatment, & Seed Treatment), Crop, and Regional Forecast, 2020 – 2027.” The report further observes that the market was worth USD...

Continue reading

Mikros Systems Corporation Reports Second Quarter Financial Results; Returns to Profitability

Princeton, N.J., Aug. 14, 2020 (GLOBE NEWSWIRE) — Mikros Systems Corporation (OTCQB: MKRS), an advanced technology company specializing in electronic systems technology for advanced maintenance in military, industrial and commercial applications, today announced financial results for the second quarter of 2020.Mikros generated revenues of $1,844,923 during the three months ended June 30, 2020 approximately equal to second quarter 2019 revenues of $1,853,503.  Cost of sales for the three months ended June 30, 2020 was $734,223 compared to $792,151 for the three months ended June 30, 2019, a decrease of $57,928 or 7%.Mikros reported net income of $154,030 in the three months ended June 30, 2020 as compared to a loss of $3,721 in three months ended June 30, 2019.“We are delighted to report a return to profitability in the second quarter,”...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.